| Pharmacotherapy: a pathophysiologic approach JT DiPiro, RL Talbert, GC Yee, GR Matzke, BG Wells, LM Posey McGraw-Hill Education 4, 141-2, 2014 | 3744 | 2014 |
| Drug dosing consideration in patients with acute and chronic kidney disease—a clinical update from Kidney Disease: Improving Global Outcomes (KDIGO) GR Matzke, GR Aronoff, AJ Atkinson Jr, WM Bennett, BS Decker, ... Kidney international 80 (11), 1122-1137, 2011 | 525 | 2011 |
| Clinical pharmacokinetics of vancomycin GR Matzke, GG Zhanel, DRP Guay Clinical pharmacokinetics 11, 257-282, 1986 | 482 | 1986 |
| Pharmacokinetics of vancomycin in patients with various degrees of renal function GR Matzke, RW Mcgory, CE Halstenson, WF Keane Antimicrobial agents and chemotherapy 25 (4), 433-437, 1984 | 461 | 1984 |
| Validation of the five‐drug “Pittsburgh cocktail” approach for assessment of selective regulation of drug‐metabolizing enzymes RF Frye, GR Matzke, A Adedoyin, JA Porter, RA Branch Clinical Pharmacology & Therapeutics 62 (4), 365-376, 1997 | 316 | 1997 |
| Liver disease selectively modulates cytochrome P450–mediated metabolism RF Frye, NK Zgheib, GR Matzke, D Chaves‐Gnecco, M Rabinovitz, ... Clinical Pharmacology & Therapeutics 80 (3), 235-245, 2006 | 280 | 2006 |
| Analgesics and the kidney: summary and recommendations to the Scientific Advisory Board of the National Kidney Foundation from an ad hoc Committe of the National Kidney Foundation WL Henrich, LE Agodoa, B Barrett, WM Bennett, RC Blantz, ... American journal of kidney diseases 27 (1), 162-165, 1996 | 241 | 1996 |
| Antimicrobial dosing concepts and recommendations for critically ill adult patients receiving continuous renal replacement therapy or intermittent hemodialysis BH Heintz, GR Matzke, WE Dager Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 29 (5 …, 2009 | 234 | 2009 |
| Current concepts in the management of peritonitis in patients undergoing continuous ambulatory peritoneal dialysis PK Peterson, G Matzke, WF Keane Reviews of infectious diseases 9 (3), 604-612, 1987 | 189 | 1987 |
| Pharmacokinetics of cefepime in subjects with renal insufficiency RH Barbhaiya, CA Knupp, ST Forgue, GR Matzke, DRP Guay, KA Pittman Clinical Pharmacology & Therapeutics 48 (3), 268-276, 1990 | 161 | 1990 |
| Hepatic drug metabolism and transport in patients with kidney disease TD Nolin, RF Frye, GR Matzke American journal of kidney diseases 42 (5), 906-925, 2003 | 150 | 2003 |
| Validity of creatinine clearance estimates in the assessment of renal function DR Luke, CE Halstenson, JA Opsahl, GR Matzke Clinical Pharmacology & Therapeutics 48 (5), 503-508, 1990 | 150 | 1990 |
| Interactive preventive health record to enhance delivery of recommended care: a randomized trial AH Krist, SH Woolf, SF Rothemich, RE Johnson, JE Peele, ... The Annals of Family Medicine 10 (4), 312-319, 2012 | 137 | 2012 |
| Determinants of vancomycin clearance by continuous venovenous hemofiltration and continuous venovenous hemodialysis MS Joy, GR Matzke, RF Frye, PM Palevsky American journal of kidney diseases 31 (6), 1019-1027, 1998 | 131 | 1998 |
| Apparent biliary pseudolithiasis during ceftriaxone therapy KL Heim-Duthoy, EM Caperton, R Pollock, GR Matzke, D Enthoven, ... Antimicrobial agents and chemotherapy 34 (6), 1146-1149, 1990 | 129 | 1990 |
| Impact of a pharmacist–physician collaborative care model on patient outcomes and health services utilization GR Matzke, LR Moczygemba, KJ Williams, MJ Czar, WT Lee The Bulletin of the American Society of Hospital Pharmacists 75 (14), 1039-1047, 2018 | 128 | 2018 |
| Drug administration in patients with renal insufficiency: minimising renal and extrarenal toxicity GR Matzke, RF Frye Drug safety 16, 205-231, 1997 | 128 | 1997 |
| Effects of magnesium-aluminum hydroxide and calcium carbonate antacids on bioavailability of ofloxacin S Flor, DR Guay, JA Opsahl, K Tack, GR Matzke Antimicrobial agents and chemotherapy 34 (12), 2436-2438, 1990 | 125 | 1990 |
| A primer on continuous renal replacement therapy for critically ill patients MS Joy, GR Matzke, DK Armstrong, MA Marx, BJ Zarowitz Annals of Pharmacotherapy 32 (3), 362-375, 1998 | 121 | 1998 |
| Unintended immunomodulation: part II. Effects of pharmacological agents on cytokine activity KM ALKharfy, JA Kellum, GR Matzke Shock 13 (5), 346-360, 2000 | 106 | 2000 |
